NCT00002693View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 1995

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions
LeukemiaNeutropenia
Interventions
BIOLOGICAL

filgrastim

DRUG

carboplatin

DRUG

topotecan hydrochloride

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER

NCT00002693 - Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia | Biotech Hunter | Biotech Hunter